{"id":753804,"date":"2023-05-02T16:04:01","date_gmt":"2023-05-02T20:04:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/"},"modified":"2023-05-02T16:04:01","modified_gmt":"2023-05-02T20:04:01","slug":"gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/","title":{"rendered":"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO and SUZHOU, China and SHANGHAI, China, May  02, 2023  (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it plans to release unaudited financial results for the first quarter ended March 31, 2023 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, May 15, 2023. The management team will host a live audio webcast and conference call at 8:00 AM Eastern Time.<\/p>\n<p align=\"left\">\n        <strong>Conference call and webcast details:<\/strong><br \/>\n        <br \/>Monday, May 15, 2023 @ 8:00am ET<br \/>Investor domestic dial-in: (800) 715-9871 <br \/>Investor international dial-in: (646) 307-1963<br \/>Conference ID: 2756776<\/p>\n<p>Live webcast link:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pBaCgyrGc2KK96_ROXh0mjrET8efdenFqhVLBqm9sp-kVtljHBk3CeDbe4CTG8sTm-ntjktXStuRYEGrP0Sv20RXc6l_5e3CasPLdTWwH5XGZcYHb-B0v8J0I9grSv0Sru1L4yZwrrgoydI24pPwTFEOI46WpzUh9J3i5HJRxJXar2a9LpGZKqMWRohMEPx8pFGNmO1pytiyD3SVT7OZpu6FiItPc58quE2QJapyl-qT9gb1a_8mWtJi5ZZyp35g4nYE2-AaEDHC0oIxSF04pnP8u7KzT7T5RioCr3co_umqvu2kYe5NUOtnAz3cSdQYADFRiMhtnZ9S4NGpdwV17iy1m5jZWIYi5kt5b8YOR0wSJAAcT6mlJqV5b4PsYUdMP0j_sBj7m4EwRbK9uzhIsiGdRp6cbU6jCYiJlewtPw7H7Qd6wHFqx-aRg5HNDKn3xjnNJW1wp1LDnhYI-unotA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.gracellbio.com\/news-events\/events-and-presentations<\/a><\/p>\n<p>A replay of the webcast will be available on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kK9txTVsQwBSINvKSS6R1x2wN8_Dz0NsgIE85rKWV1aZ_jTp6jP0GLmbcuQh6Pgw4Q5ITuk53gDV7JvbuvTgkfFP3bQz21Q9gcNrUJs4Auh_D7EG6fPGM8YYpyz_kbx0haDSYDjzg0LlKwxAY_5Vv8KxXB-Su62MckkAvsuVV2yp5SNHaqbZt03yswi515xlhz2Iql7ctcu-LVVQ1dGbAWncO7MgziZrQk7t0jyW-Rj1VQr5zmOsibuYcef7CfRk07tKg2YCifguw1rRvPCk2cZYWmNy07xTkVNiFuAgge1QeudvLnL8AcvdhaNcls_he2XVaeBdB7414RxL1KhL5ZWAZdK6v6zolN_4qGdu7quX0SSu85ZTCEbgcx4LDO0OQBXKRv-sO_P-ilPeUYW5z1YoT82PMPRMJ2mkA7uBk-RihPg1NqLL3zILOa5Bu6Ko8gXXSClDa-B7L3n6WgFEXw==\" rel=\"nofollow noopener\" target=\"_blank\">ir.gracellbio.com<\/a>\u00a0shortly after the conclusion of the event for 90 days.<\/p>\n<p>\n        <strong>About Gracell<\/strong><br \/>\n        <br \/>Gracell Biotechnologies Inc.\u00a0(&#8220;Gracell&#8221;) is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART\u2122\u00a0technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0F6qkC22w4PUYMUwTSrh2hEDlSB5jPjF5all_2KL2LgnMGjjS-RmJDNrJc4nL0rp3FlN-V7SGRQcO0pOBKsjzkMNN2cOg6XgaOwe6nEt-Uw=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.gracellbio.com\/<\/a>. Follow\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PDEpKdDHYD2T-wgO4QJ2KwXpFoWZZKZRR5q_TMcUDZtmjL3t-ir0yaMKhz9FNNRTwvZkUvqj9YaF5vqmu3dfzzglHWXxt5nnXkpOu6NgnSs=\" rel=\"nofollow noopener\" target=\"_blank\">@GracellBio<\/a>\u00a0on LinkedIn.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Nzc4OTRkOGEtYzk3Ni00NGYxLWExMWQtNmQ2ZDZiNjlhNTFkLTEyMTU4Mzk=\/tiny\/Gracell-Biotechnologies-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Media contacts\r\nMarvin Tang\r\nmarvin.tang@gracellbio.com\r\nKyle Evans\r\nkyle.evans@westwicke.com\r\n\r\nInvestor contacts\r\nGracie Tong\r\ngracie.tong@gracellbio.com\r\nStephanie Carrington\r\nstephanie.carrington@westwicke.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO and SUZHOU, China and SHANGHAI, China, May 02, 2023 (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it plans to release unaudited financial results for the first quarter ended March 31, 2023 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, May 15, 2023. The management team will host a live audio webcast and conference call at 8:00 AM Eastern Time. Conference call and webcast details: Monday, May 15, 2023 @ 8:00am ETInvestor domestic dial-in: (800) 715-9871 Investor international dial-in: (646) 307-1963Conference ID: 2756776 Live webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753804","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO and SUZHOU, China and SHANGHAI, China, May 02, 2023 (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it plans to release unaudited financial results for the first quarter ended March 31, 2023 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, May 15, 2023. The management team will host a live audio webcast and conference call at 8:00 AM Eastern Time. Conference call and webcast details: Monday, May 15, 2023 @ 8:00am ETInvestor domestic dial-in: (800) 715-9871 Investor international dial-in: (646) 307-1963Conference ID: 2756776 Live webcast &hellip; Continue reading &quot;Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T20:04:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023\",\"datePublished\":\"2023-05-02T20:04:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/\",\"name\":\"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=\",\"datePublished\":\"2023-05-02T20:04:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/","og_locale":"en_US","og_type":"article","og_title":"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023 - Market Newsdesk","og_description":"SAN DIEGO and SUZHOU, China and SHANGHAI, China, May 02, 2023 (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it plans to release unaudited financial results for the first quarter ended March 31, 2023 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, May 15, 2023. The management team will host a live audio webcast and conference call at 8:00 AM Eastern Time. Conference call and webcast details: Monday, May 15, 2023 @ 8:00am ETInvestor domestic dial-in: (800) 715-9871 Investor international dial-in: (646) 307-1963Conference ID: 2756776 Live webcast &hellip; Continue reading \"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-02T20:04:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023","datePublished":"2023-05-02T20:04:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/"},"wordCount":242,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/","name":"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=","datePublished":"2023-05-02T20:04:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDA5OCM1NTY5ODQxIzIyMDQyODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-first-quarter-2023-financials-on-monday-may-15-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gracell Biotechnologies to Report First Quarter 2023 Financials on Monday, May 15, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753804"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753804\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}